David Edwin Wildt developed and applied assisted reproductive technologies to conserve rare and endangered wildlife species in the US during the twentieth and twenty-first centuries. He advocated genome resource banks to help preserve biodiversity, and he advocated for practical ethics to guide wildlife reproductive biologists when they use technology and environmental planning. Wildt often focused on the cheetah (Acinonyx jubatus), but he researched greater than fifty vertebrate species. In the early decades of the twenty-first century, he directed the Smithsonian's Conservation Biology Institute Center for Species Survival in Front Royal, Virginia. He researched reproductive biology and population genetics, used assisted reproduction technologies (ART) for wildlife species, and showed researchers how to utilize noninvasive techniques to monitor the hormones in organisms and their reproductive behaviors.

In 1993, the NIH published the Revitalization Act that established guidelines for minorities’ and women’s participation in clinical research. Before the 1990s, investigators largely excluded women from their research based on the 1979 guidance from the US Food and Drug Administration, or FDA. The FDA urged investigators to exclude any woman who was or could become, pregnant to protect the woman and any developing fetuses from harm. Between 1979 and 1993, several other US governmental agencies urged investigators to increase the number of women in their clinical research to improve the state of women’s healthcare. After Congress passed the National Institutes of Health Revitalization Act, hereafter Revitalization Act of 1993, investigators who used NIH funds for clinical research were required to include both women and minorities in their clinical research. The Revitalization Act established the Office of Research on Women’s Health headquartered in Washington, DC and required investigators to include women in their clinical research, thus improving the quality of women’s health research.